| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000260196.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.021425704 |
Resistant |
| ENSG00000260196.1 |
Ponatinib |
Brain lower grade glioma |
0.048674458 |
Resistant |
| ENSG00000260196.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.033409521 |
Resistant |
| ENSG00000260196.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026343186 |
Sensitive |
